Sinphar Pharmaceutical Co Ltd (1734) — Capital Reinvestment Ratio

Latest as of March 2026: 0.87x

Sinphar Pharmaceutical Co Ltd (1734) has a Capital Reinvestment Ratio of 0.87x as of March 2026, meaning it reinvests 1% of its operating cash flow (NT$116.42 Million) in capital expenditures (NT$101.07 Million). See Sinphar Pharmaceutical Co Ltd (1734) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.87x
Capex / Operating Cash Flow

Operating Cash Flow

NT$116.42 Million
TWD

Capital Expenditures

NT$101.07 Million
TWD

Data as of

Mar 2026
Most recent filing

Sinphar Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)

This chart tracks Sinphar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods.

Annual Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd (2003–2025)

Year-by-year Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see Sinphar Pharmaceutical Co Ltd (1734) total market value.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.34x NT$584.66 Million NT$200.94 Million ▼ -20.5%
2024 0.43x NT$593.51 Million NT$256.71 Million ▼ -57.4%
2023 1.02x NT$296.37 Million NT$300.94 Million ▲ +181.4%
2022 0.36x NT$425.30 Million NT$153.44 Million ▼ -69.7%
2021 1.19x NT$135.54 Million NT$161.44 Million ▲ +10.5%
2020 1.08x NT$146.39 Million NT$157.77 Million ▼ -66.5%
2018 3.22x NT$79.50 Million NT$255.69 Million ▲ +313.5%
2017 0.78x NT$219.87 Million NT$171.00 Million ▼ -69.8%
2016 2.58x NT$87.18 Million NT$224.85 Million ▲ +75.6%
2015 1.47x NT$280.53 Million NT$412.04 Million ▼ -25.8%
2014 1.98x NT$148.58 Million NT$294.29 Million ▼ -1.6%
2013 2.01x NT$297.09 Million NT$598.16 Million ▼ -11.8%
2012 2.28x NT$164.45 Million NT$375.19 Million ▲ +42.3%
2011 1.60x NT$225.58 Million NT$361.69 Million ▲ +43.2%
2010 1.12x NT$261.49 Million NT$292.75 Million ▲ +57.9%
2009 0.71x NT$309.94 Million NT$219.71 Million ▼ -17.6%
2008 0.86x NT$271.01 Million NT$233.25 Million ▼ -63.7%
2007 2.37x NT$174.85 Million NT$414.90 Million ▲ +58.5%
2006 1.50x NT$166.57 Million NT$249.44 Million ▼ -3.1%
2005 1.55x NT$122.09 Million NT$188.76 Million ▲ +68.1%
2004 0.92x NT$174.81 Million NT$160.79 Million ▼ -57.3%
2003 2.16x NT$120.84 Million NT$260.50 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow